episode-header-image

Oct 2025

17m 38s

Review Series on Follicular Lymphoma

AMERICAN SOCIETY OF HEMATOLOGY

About this episode

Up next

New Research: Mitochondrial DNA in TRALI and Venetoclax-Obinituzumab in CLL Trials

In this week's episode, associate editor Dr. James Griffin interviews researchers Dr. John Semple and Dr. Othman Al-Sawaf on their groundbreaking studies on transfusion-related acute lung injury and chronic lymphocytic leukemia treatment. Dr. Semple explored how mitochondrial DNA ... Show More

Bispecific Antibodies in Aggressive B-Cell Lymphoma: Real-World Insights and Future Directions

In this week's episode, Blood editor Dr. Laura Michaelis interviews author Dr. Taylor Brooks on his latest paper published in volume 146 issue 18 of Blood Journal. The conversation discusses outcomes of bispecific antibodies (epcoritamab or glofitamab) in treating aggressive B-ce ... Show More

Breakthroughs in Multiple Myeloma Treatment and Von Willebrand Disease Mechanisms

In this week's episode of the Blood Podcast, Associate Editor Dr. James Griffin interviews Drs. Binod Dhakal and Ruben Bierings about their respective papers published in this week's issue of Blood. Dr. Dhakal presents his study on using talquetamab, a bispecific antibody, as a b ... Show More

Recommended Episodes

Multiple Myeloma

<p>This week’s episode is part 2 of our plasma cell dyscrasias series. We will go over the important details on risk stratification, as well as initial and relapse treatment options for Multiple Myeloma, with key details on the pharmacology of myeloma drugs.</p><p><br/></p>

Episode 116: AML Series, Pt. 2 - MDS/AML Diagnosis and Risk Stratification

<p>In this week’s episode, we discuss the diagnostic criteria and risk stratification for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), building on our discussion from last week. Also, if you have not done so, please do check out our hemepath series to ensure y ... Show More

Episode 120: AML Series, Pt 6 - AML Consolidation: Therapeutic Approaches

<p>This week, we move to our next phases of therapy for AML, which are consolidation and maintenance. Be sure to check out our prior episodes for a discussion on initial workup and how we incorporate recurrent genetic abnormalities into how we think about AML. Check out figure 1 ... Show More

Acute Leukemias

Send us Fan MailNinja Nerds,Welcome to the Ninja Nerd Podcast with Zach and Rob! In this episode, we dive deep into Acute Leukemias, breaking down their pathophysiology, clinical presentation, and management. We explore the key differences between Acute Myeloid Leukemia (AML) and ... Show More

Chapter 11: Hematology and Oncology (Part 5)

In this episode from the Hematology and Oncology chapter of Crush Step 1, we continue the discussion of pathology covering: - Clotting Factor Deficiencies - Hereditary Thrombosis Syndromes - White Blood Cell Neoplastic Proliferation (Leukemias and Lymphomas) Learn more about your ... Show More

Episode 122: AML Series, Pt 8 - AML Maintenance Therapies

<p>This week, we continue our series focusing on acute myeloid leukemia. In this episode, we talk about maintenance therapies in AML.</p><p>Episode contents: </p><p>- A recap of cytarabine consolidation </p><p>- Why do we do maintenance therapy?</p><p>- What are hypomethylating a ... Show More

CAR T-cell Therapy in AML: State of the Art

Tune in to our podcast for an in-depth discussion on immunotherapeutic strategies for Acute Myeloid Leukemia (AML). In this episode, we feature Dr Sarah Tettamanti, a senior scientist at the Fondazione Tettamanti Research Centre in Italy, who shares her expertise on CAR T-cell th ... Show More

Episode 044: Myeloma Series, Pt.5 - Myeloma Treatment

<p class="" style="white-space:pre-wrap;">In this continuation of our myeloma series, we build on our prior discussion about myeloma pharmacology, this time discussing how to select the optimal regimen for treatment of our patients.</p><p class="" style="white-space:pre-wrap;">Co ... Show More

Chapter 11: Hematology and Oncology (Part 6)

This episode is a continuation of the Hematology and Oncology chapter of Crush Step 1. Content covered includes: - Lymphomas - Histiocyte Disorders (Langerhans Cell Histiocytosis [LCH] and Histiocytosis X) - Plasma Cell Disorders (Multiple Myeloma, Waldenström Macroglobulinemia [ ... Show More